Using a highly sensitive single-molecule assay, we found that children hospitalized with CM or SMA had elevated levels of plasma tau, a marker of injury to neuronal axons, and that tau levels were associated with disease severity, mortality, and persistent NCI in children with CM. The gene discussed is MAPT; the disease is cutaneous mastocytosis.